Testing effectiveness (Phase 2)Study completedNCT01738646
What this trial is testing
Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
Who this might be right for
Recurrent Glioblastoma MultiformeMalignant GliomaAdult Brain Tumor
Duke University 48